Clinical Data Operational Readiness Framework.

1. Problem the framework addresses

Clinical data delivery often fails at the boundaries between functions rather than within one technical task. A study can be highly complete while still carrying a late statistical decision, unresolved external-data dependency, insufficient review window, metadata mismatch, or unclear escalation path. Percentage complete therefore does not describe readiness well enough for high-consequence milestones.

2. Intended use

CDOR is intended for milestone preparation across Statistical Programming, Biostatistics, Data Management, Regulatory, Clinical/Study leadership, Safety/Pharmacovigilance, and Submission Operations/Data Standards. It is designed for generalized operational planning around database lock, dry runs/interims, health-authority requests, study startup, late change, submission readiness, and safety updates.

It intentionally does not require study datasets, protocols, specifications, patient information, or sponsor-confidential documents.

3. The seven readiness dimensions

4. Workflow construction

1. Frame the situation. Select the role, milestone, target date, and primary deliverable.
2. Identify gating dependencies. Surface decisions, data, transfers, access, reviews, or systems that can prevent progress.
3. Prioritize by impact and latest acceptable date. A risk becomes operationally important when it can materially affect the milestone and the remaining time to resolve it is limited.
4. Translate the shared milestone backbone through the selected role. The milestone remains common, but responsibilities, questions, and handoffs change.
5. Define closure evidence. Each checkpoint should specify what demonstrates completion, review, or accepted exception.

5. Timing model

CDRN generates suggested checkpoint dates by proportionally distributing a milestone-specific backbone across the available time window. These dates are planning defaults, not industry requirements. Users can adjust checkpoint dates before saving or exporting a plan when the study-specific critical path requires a different sequence.

6. Role lenses

The role lens changes the accountability view without pretending that one function owns the entire milestone. For example, a database-lock checkpoint may ask Data Management about source-data readiness, Biostatistics about analysis decisions, Programming about executable and QC-ready artifacts, Regulatory about submission implications, Clinical leadership about protocol/clinical decisions and escalation, Safety/PV about safety-cut and event readiness, and Submission Operations/Data Standards about regional technical and package readiness.

7. Evidence model

CDOR treats readiness as demonstrated state. Typical evidence includes decision logs, data-cut records, reconciliation outputs, independent QC records, validation reports, review dispositions, package inventories, approvals, and final version references. Evidence should be proportionate to the milestone and compatible with sponsor-controlled systems.

8. Worked patterns

9. Boundaries and limitations

• CDOR does not define regulatory requirements or replace agency guidance.
• CDOR does not override protocol, SAP, sponsor SOPs, controlled standards, or accountable functional decisions.
• Generic role guidance cannot represent every organizational model; responsibility maps must be adapted.
• Suggested timing is not a universal best practice.
• The public methodology contains generalized examples and should not receive confidential study content.

10. Validation status

This version is an editorial methodology baseline. Independent cross-functional domain review and external pilot evidence are not yet claimed. CDRN keeps those categories separate from author-created content. Future validation should document review across Biostatistics, Data Management, Regulatory, Clinical, and Statistical Programming, then measure whether independent practitioners find the framework relevant, reusable, and sufficiently complete for the intended scenarios.

11. Readiness Intelligence extension

Readiness Intelligence is the upstream signal-to-action layer of CDRN. It accepts a generalized operational signal, determines applicability and urgency, maps the affected artifacts and functions, proposes controlled actions, and defines closure evidence before handing the situation to Navigator for dated role-specific planning.

1. Signal. Describe the change, request, delay, finding, or standards event without uploading confidential study content.
2. Applicability decision. Determine whether the signal affects the selected milestone, deliverable, region, or operating context.
3. Affected artifacts. Identify the data, specifications, outputs, metadata, documents, reviews, and handoffs that may need reassessment.
4. Controlled action. Assign accountable functions, priorities, latest acceptable dates, and escalation points.
5. Closure evidence. Retain the records that demonstrate review, implementation, independent checking, approval, or accepted exception.

The analyzer is deterministic decision support based on generalized scenarios. Its suggested impact and readiness score are planning aids, not validated predictions, regulatory determinations, or substitutes for sponsor procedures and accountable judgment.

12. Versioning and citation

Material methodology changes are recorded in the public Changelog. Use the Citation page for the current suggested citation and machine-readable citation information.